Clovis Oncology’s stock soars 49% premarket after positive phase 3 trial results

0 Comments 4 view(s)

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.